{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:44:49Z","timestamp":1772552689282,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2012CB966402"],"award-info":[{"award-number":["2012CB966402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81370873"],"award-info":[{"award-number":["81370873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1253-1","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T12:04:05Z","timestamp":1498565045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy"],"prefix":"10.1186","volume":"15","author":[{"given":"Yongwei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinning","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-6386(00)70316-7","volume":"35","author":"P Maisonneuve","year":"2000","unstructured":"Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia\/New Zealand: results from an international comparative study. Am J Kidney Dis. 2000;35:157\u201365.","journal-title":"Am J Kidney Dis"},{"key":"1253_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","volume":"5","author":"MB Duran-Salgado","year":"2014","unstructured":"Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5:393\u20138.","journal-title":"World J Diabetes"},{"key":"1253_CR3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s001250100000","volume":"44","author":"ME Cooper","year":"2001","unstructured":"Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia. 2001;44:1957\u201372.","journal-title":"Diabetologia"},{"key":"1253_CR4","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1152\/ajpendo.00184.2011","volume":"302","author":"H Wang","year":"2012","unstructured":"Wang H, Jiang YW, Zhang WJ, Xu SQ, Liu HL, Yang WY, et al. Differential activations of PKC\/PKA related to microvasculopathy in diabetic GK rats. Am J Physiol Endocrinol Metab. 2012;302:E173\u201382.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1253_CR5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/138945007781386884","volume":"8","author":"S Yamagishi","year":"2007","unstructured":"Yamagishi S, Fukami K, Ueda S, Okuda S. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr Drug Targets. 2007;8:952\u20139.","journal-title":"Curr Drug Targets"},{"key":"1253_CR6","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMicm066227","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560\u201372.","journal-title":"N Engl J Med"},{"key":"1253_CR7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565\u201376.","journal-title":"N Engl J Med"},{"key":"1253_CR8","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/TP.0b013e318190b052","volume":"86","author":"GL Warnock","year":"2008","unstructured":"Warnock GL, Thompson DM, Meloche RM, Shapiro RJ, Ao Z, Keown P, et al. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation. 2008;86:1762\u20136.","journal-title":"Transplantation"},{"key":"1253_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/TP.0b013e31820437f3","volume":"91","author":"DM Thompson","year":"2011","unstructured":"Thompson DM, Meloche M, Ao Z, Paty B, Keown P, Shapiro RJ, et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 2011;91:373\u20138.","journal-title":"Transplantation"},{"key":"1253_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MOT.0000000000000045","volume":"19","author":"TB Dunn","year":"2014","unstructured":"Dunn TB. Life after pancreas transplantation: reversal of diabetic lesions. Curr Opin Organ Transpl. 2014;19:73\u20139.","journal-title":"Curr Opin Organ Transpl"},{"key":"1253_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2337\/diabetes.50.3.521","volume":"50","author":"H Zulewski","year":"2001","unstructured":"Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes. 2001;50:521\u201333.","journal-title":"Diabetes"},{"key":"1253_CR12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3727\/000000005783982602","volume":"14","author":"F Atouf","year":"2005","unstructured":"Atouf F, Choi Y, Fowler MJ, Poffenberger G, Vobecky J, Ta M, et al. Generation of islet-like hormone-producing cells in vitro from adult human pancreas. Cell Transpl. 2005;14:735\u201348.","journal-title":"Cell Transpl"},{"key":"1253_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/scrt352","volume":"4","author":"WJ Zhang","year":"2013","unstructured":"Zhang WJ, Xu SQ, Cai HQ, Men XL, Wang Z, Lin H, et al. Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment. Stem Cell Res Ther. 2013;4:141.","journal-title":"Stem Cell Res Ther"},{"key":"1253_CR14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26:443\u201352.","journal-title":"Nat Biotechnol"},{"key":"1253_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/cr.2007.28","volume":"17","author":"W Jiang","year":"2007","unstructured":"Jiang W, Shi Y, Zhao D, Chen S, Yong J, Zhang J, et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007;17:333\u201344.","journal-title":"Cell Res"},{"key":"1253_CR16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00125-007-0634-z","volume":"50","author":"JH Shim","year":"2007","unstructured":"Shim JH, Kim SE, Woo DH, Kim SK, Oh CH, McKay R, et al. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia. 2007;50:1228\u201338.","journal-title":"Diabetologia"},{"key":"1253_CR17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db07-0720a","volume":"57","author":"K Brands","year":"2008","unstructured":"Brands K, Colvin E, Williams LJ, Wang R, Lock RB, Tuch BE. Reduced immunogenicity of first-trimester human fetal pancreas. Diabetes. 2008;57:627\u201334.","journal-title":"Diabetes"},{"key":"1253_CR18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biocel.2011.02.006","volume":"43","author":"MT Ma","year":"2011","unstructured":"Ma MT, Leung KK, Tsang KS, Leung PS. Reduced immunogenicity of pancreatic progenitor cells derived from first-trimester human fetal pancreas. Int J Biochem Cell Biol. 2011;43:812\u201320.","journal-title":"Int J Biochem Cell Biol"},{"key":"1253_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","volume":"311","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89\u201393.","journal-title":"N Engl J Med"},{"key":"1253_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2337\/diacare.18.7.1013","volume":"18","author":"JC Chan","year":"1995","unstructured":"Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care. 1995;18:1013\u20136.","journal-title":"Diabetes Care"},{"key":"1253_CR21","doi-asserted-by":"crossref","first-page":"281536","DOI":"10.1155\/2008\/281536","volume":"2008","author":"L Rebsomen","year":"2008","unstructured":"Rebsomen L, Khammar A, Raccah D, Tsimaratos M. C-peptide effects on renal physiology and diabetes. Exp Diabetes Res. 2008;2008:281536.","journal-title":"Exp Diabetes Res"},{"key":"1253_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.mnh.0000165885.85803.a8","volume":"14","author":"TB Huber","year":"2005","unstructured":"Huber TB, Benzing T. The slit diaphragm: a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens. 2005;14:211\u20136.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1253_CR23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00034.2007","volume":"88","author":"SF Steinberg","year":"2008","unstructured":"Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev. 2008;88:1341\u201378.","journal-title":"Physiol Rev"},{"key":"1253_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-8981(00)00240-0","volume":"297","author":"R Lehmann","year":"2000","unstructured":"Lehmann R, Schleicher ED. Molecular mechanism of diabetic nephropathy. Clin Chim Acta. 2000;297:135\u201344.","journal-title":"Clin Chim Acta"},{"key":"1253_CR25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbrc.2015.02.022","volume":"458","author":"S Xu","year":"2015","unstructured":"Xu S, Jiang Y, Wang H, Wang Z, Liu H, Peng L, et al. C-peptide ameliorates renal injury in type 2 diabetic rats through protein kinase A-mediated inhibition of fibronectin synthesis. Biochem Biophys Res Commun. 2015;458:674\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"1253_CR26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.transproceed.2004.04.055","volume":"36","author":"AO Gaber","year":"2004","unstructured":"Gaber AO, Fraga D, Kotb M, Lo A, Sabek O, Latif K. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transpl Proc. 2004;36:1108\u201310.","journal-title":"Transpl Proc"},{"key":"1253_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1464-5491.2000.00274.x","volume":"17","author":"BL Johansson","year":"2000","unstructured":"Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med. 2000;17:181\u20139.","journal-title":"Diabet Med"},{"key":"1253_CR28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/diacare.26.4.1129","volume":"26","author":"P Fiorina","year":"2003","unstructured":"Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, et al. Long-term beneficial effect of islet transplantation on diabetic macro-\/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care. 2003;26:1129\u201336.","journal-title":"Diabetes Care"},{"key":"1253_CR29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000289864","volume":"31","author":"CE Hills","year":"2010","unstructured":"Hills CE, Brunskill NJ, Squires PE. C-peptide as a therapeutic tool in diabetic nephropathy. Am J Nephrol. 2010;31:389\u201397.","journal-title":"Am J Nephrol"},{"key":"1253_CR30","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1152\/ajpendo.00130.2014","volume":"307","author":"GL Yosten","year":"2014","unstructured":"Yosten GL, Maric-Bilkan C, Luppi P, Wahren J. Physiological effects and therapeutic potential of proinsulin C-peptide. Am J Physiol Endocrinol Metab. 2014;307:E955\u201368.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1253_CR31","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1046\/j.1523-1755.2001.00964.x","volume":"60","author":"B Samnegard","year":"2001","unstructured":"Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int. 2001;60:1258\u201365.","journal-title":"Kidney Int"},{"key":"1253_CR32","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ndt\/gfh163","volume":"19","author":"B Samnegard","year":"2004","unstructured":"Samnegard B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, et al. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats. Nephrol Dial Transpl. 2004;19:1385\u201391.","journal-title":"Nephrol Dial Transpl"},{"key":"1253_CR33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jdiacomp.2013.07.002","volume":"27","author":"ER Flynn","year":"2013","unstructured":"Flynn ER, Lee J, Hutchens ZM Jr., Chade AR, Maric-Bilkan C. C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat. J Diabetes Complic. 2013;27:538\u201347.","journal-title":"J Diabetes Complic"},{"key":"1253_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00402543","volume":"35","author":"BL Johansson","year":"1992","unstructured":"Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35:121\u20138.","journal-title":"Diabetologia"},{"key":"1253_CR35","first-page":"976","volume":"77","author":"BL Johansson","year":"1993","unstructured":"Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab. 1993;77:976\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"1253_CR36","first-page":"134","volume":"8","author":"MA Dam ten","year":"1993","unstructured":"ten Dam MA, Werter CJ, Popp-Snijders C, Donker AJ, ten Kate RW. Renal handling of insulin and C-peptide in patients with non-insulin-dependent diabetes mellitus. Nephrol Dial Transpl. 1993;8:134\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"1253_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.niox.2003.08.004","volume":"9","author":"T Wallerath","year":"2003","unstructured":"Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, et al. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide. 2003;9:95\u2013102.","journal-title":"Nitric Oxide"},{"key":"1253_CR38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1741-7015-11-160","volume":"11","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, Zhou H, et al. Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I\/II clinical trial. BMC Med. 2013;11:160.","journal-title":"BMC Med"},{"key":"1253_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00441-016-2499-2","volume":"368","author":"J Xv","year":"2017","unstructured":"Xv J, Ming Q, Wang X, Zhang W, Li Z, Wang S, et al. Mesenchymal stem cells moderate immune response of type 1 diabetes. Cell Tissue Res. 2017;368:239\u201348.","journal-title":"Cell Tissue Res"},{"key":"1253_CR40","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2337\/db11-0844","volume":"61","author":"EJ Bassi","year":"2012","unstructured":"Bassi EJ, Moraes-Vieira PM, Moreira-Sa CS, Almeida DC, Vieira LM, Cunha CS, et al. Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes. 2012;61:2534\u201345.","journal-title":"Diabetes"},{"key":"1253_CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1475-2840-12-128","volume":"12","author":"CC Hughey","year":"2013","unstructured":"Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, et al. Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol. 2013;12:128.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T01:11:50Z","timestamp":1589764310000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1253-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1253-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]},"article-number":"147"}}